"Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial." by Douglas K. Rex

Selected Works of Daniel Lorch, MD

Follow Contact

Article

Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial.

Digestive and Liver Disease (2021)

Douglas K. Rex, Indiana University
Raj Bhandari, Delta Research Partners, Bastrop, LA, United States.
Daniel G. Lorch, Pulmonary Associates of Brandon and Sun City, Sun City, FL, United States.
Michael Meyers, Consultant to PAION UK Limited, United Kingdom.
Frank Schippers, PAION Deutschland GmbH, Germany.
David Bernstein, Hofstra University

Link

Disciplines

Medicine and Health Sciences and
Anesthesiology

Publication Date

January 1, 2021

DOI

10.1016/J.DLD.2020.10.039

Citation Information

Douglas K. Rex, Raj Bhandari, Daniel G. Lorch, Michael Meyers, et al.. "Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial." Digestive and Liver Disease Vol. 53 Iss. 1 (2021) p. 94 - 101
Available at: http://works.bepress.com/daniel-lorch/2/